Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMP) have been implicated in the pathology of Parkinson’s and Alzheimer’s diseases, where MMP can cleave amyloid beta [51]. Here, TIMP1 is linked to Parkinson disease.